HKEX Stock Code: 01093English|繁體|简体
Home > Investor Relations > Announcements & Notices
Announcements & Notices
Dec
19
VOLUNTARY ANNOUNCEMENT - THE GROUP'S HYPERTENSION AND DYSLIPIDEMIA COMBINATION DRUG "LEVAMLODIPINE MALEATE/ATORVASTATIN CALCIUM TABLET" COMMENCES PHASE III CLINICAL TRIAL
Dec
17
Voluntary Announcement - The Group's production workshop for cough suppressant product "Benzonatate Soft Capsule" passed onsite inspection by the U.S.FDA
Dec
10
VOLUNTARY ANNOUNCEMENT - TECHNOLOGY TRANSFER AGREEMENT WITH ACADEMY OF MILITARY MEDICAL SCIENCES FOR AN INNOVATIVE ANTIDEPRESSANT
Nov
28
NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
Nov
25
UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2014
Nov
17
VOLUNTARY ANNOUNCEMENT - THE GROUP'S PRODUCTION WORKSHOPS FOR CEPHALOSPORIN PRODUCTS PASSED ONSITE INSPECTION BY THE U.S. FDA
Nov
17
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL STUDY APPLICATION TO THE CENTER FOR DRUG EVALUATION FOR THE GROUP'S HEPATITIS C DRUG "SOFOSBUVIR TABLET"
Nov
14
CONTINUING CONNECTED TRANSACTIONS - WAREHOUSE STORAGE SERVICE AGREEMENT
Nov
13
DATE OF BOARD MEETING
Nov
10
VOLUNTARY ANNOUNCEMENT - Drug Registration Approval of the Group's Oncology Drug "Imatinib Mesylate Tablet"
Oct
24
SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER
Aug
29
CONTINUING CONNECTED TRANSACTIONS - MASTER STEAM SUPPLY AGREEMENT
Aug
29
NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
Aug
29
SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER AND RESUMPTION OF TRADING
Aug
28
TRADING HALT
Aug
26
2014 INTERIM RESULTS ANNOUNCEMENT
Aug
14
CONTINUING CONNECTED TRANSACTIONS WITH A WHOLLY-OWNED SUBSIDIARY OF A SUBSTANTIAL SHAREHOLDER OF AN INSIGNIFICANT SUBSIDIARY
Aug
14
DATE OF BOARD MEETING
Aug
12
CONTINUING CONNECTED TRANSACTIONS WITH A WHOLLY-OWNED SUBSIDIARY OF A SUBSTANTIAL SHAREHOLDER OF AN INSIGNIFICANT SUBSIDIARY
Jun
02
List of Directors and their Role and Function
Jun
02
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS, APPOINTMENT OF NOMINATION COMMITTEE MEMBER AND NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
May
27
SALES OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER
May
23
UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2014
May
20
List of Directors and their Role and Function
May
20
RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS, CHANGE OF THE BOARD COMMITTEES' MEMBERS AND NON-COMPLIANCE WITH RULE 3.10A THE LISTING RULES
May
20
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 20 MAY 2014
May
13
DATE OF BOARD MEETING
May
08
VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AGREEMENT
Apr
09
NOTICE OF ANNUAL GENERAL MEETING
Mar
24
CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER OFFICE
Mar
24
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
Mar
19
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Mar
19
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND RULE 3.10A OF THE LISTING RULES
Mar
12
DATE OF BOARD MEETING
Jan
29
CONNECTED TRANSACTION - ACQUISITION OF 21.43% EQUITY INTEREST IN UNIGENE BIOTECHNOLOGY CO.LTD.

Please download the latest "Acrobat Reader" to view the PDF.

© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.
Disclaimer